Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils.
Platelet-activating factor, at a concentration of 10 microM, was capable of inducing leukotriene C4 synthesis by eosinophils of healthy donors, i.e. (3.1 +/- 0.3) x 10(6) molecules leukotriene C4/cell (n = 31, mean +/- SEM, cell purity 87 +/- 2%). Reversed-phase high performance liquid chromatography analysis demonstrated the exclusive synthesis of leukotriene C4. At a concentration of 1 microM, platelet-activating factor was capable of significantly enhancing the calcium ionophore A23187, the opsonized zymosan or the arachidonic acid induced leukotriene C4 synthesis by eosinophils. These results show that PAF is capable of inducing and enhancing the leukotriene C4 formation by human eosinophils.
D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D004357:Drug Synergism; D004804:Eosinophils / Q000378:metabolism*; D006801:Humans; D010972:Platelet Activating Factor / Q000494:pharmacology*; D011863:Radioimmunoassay; D013189:SRS-A / Q000096:biosynthesis*; D013997:Time Factors; D015054:Zymosan / Q000494:pharmacology
D001095:Arachidonic Acids; D010972:Platelet Activating Factor; D013189:SRS-A; D016718:Arachidonic Acid; D000001:Calcimycin; D015054:Zymosan